Last reviewed · How we verify

NCT05746169

Discovering Cancer Risks From Environmental Contaminants and Maternal/Child Health

Terminated Last updated 30 December 2025
What this trial tests

trial testing Health Questionnaires in Cancer in 1,576 participants. Terminated before completion.

Timeline
1 September 2021
Primary endpoint
21 July 2025
21 July 2025

Quick facts

Lead sponsorUniversity of California, San Francisco
StatusTerminated
Study typeOBSERVATIONAL
Enrollment1,576
Start date1 September 2021
Primary completion21 July 2025
Estimated completion21 July 2025
Sites3 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of California, San Francisco

Who can join

18 and older, any sex, with Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The DREAM Cohort is a longitudinal observational study developed to enhance our understanding of how multiple exposures to environmental chemicals and pollutants across a diverse population of pregnant women and their offspring are linked to cancer risks. Because pregnancy induces multiple maternal hormonal and physiological changes that can increase cancer susceptibility to environmental chemical exposures, this study will focus on pregnancy as a period of particular vulnerability to toxic agents.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cancer

Currently open trials in the same condition.

Other University of California, San Francisco trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05746169.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing